Pharmaceutical News

New Delhi, Dec 24: More Indian companies are expected to open new dedicated research and development firms in foreign countries, particularly in the US and Europe, according to a report on Tuesday.

New Delhi, Dec 19: India’s pharma industry is considered to be the world's third largest by volume, and in FY 2023-24 the pharmaceutical market has been valued at $50 billion, said Union Minister of State for Chemicals and Fertilizers Anupriya Patel.

Mumbai, Dec 11: Indian regulator Central Drugs Standard Control Organisation (CDSCO) has approved Cipla to exclusively distribute and market inhaled insulin in the country, the drugmaker said on Wednesday.

New Delhi, December 7: Listed pharma company, Suven Pharmaceuticals has announced the acquisition of a controlling stake in US-based NJ Bio Inc.

New Delhi, November 28: The Indian healthcare sector is on a trajectory of rapid growth, with the pharmaceutical market poised to double from its current valuation of USD60 billion to an estimated USD120 billion by 2030, according to a report by the Organisation of Pharmaceutical Producers of India (OPPI) in collaboration with the Boston Consulting Group (BCG).

Hyderabad, Nov 28: Dr. Reddy’s Laboratories on Thursday announced the launch of Toripalimab in India to treat adults with Nasopharyngeal carcinoma (NPC) -- a rare and aggressive form of head and neck cancer that originates in the nasopharynx, the upper part of the throat.

New Delhi, Nov 27: Senores Pharmaceuticals and Dr. Reddy's Laboratories, have announced the launch of ivermectin tablets USP, 3 mg. in the US market.

New Delhi, October 15: India has emerged as a global leader in pharmaceuticals, being the third-largest producer and a key supplier of generic medicines, said Union Health Secretary Punya Salila Srivastava while addressing the annual India Leadership Summit 2024, organised by the US-India Strategic Partnership Forum.

New Delhi, October 8: The Indian pharmaceutical sector is set for a mixed quarter, with slow growth expected in the branded formulations, according to the Systematix Institutional Equities report.

New Delhi, October 2: Competition Commission of India (CCI) has approved the acquisition of Bharat Serums and Vaccines Limited by Mankind Pharma Ltd, the anti-trust regulator said in a statement.

New Delhi, October 1: Sun Pharmaceutical Industries Limited (Sun Pharma) and Philogen S.p.A (Philogen) announced a global exclusive commercialisation, licence, and supply agreement to commercialise Fibromun (L19TNF), Philogen's speciality anti-cancer immunotherapy product.

New Delhi, September 30: Revenues of Indian pharma companies are likely to expand by 9-11 per cent in the current financial year, albeit a moderation from the increase of 13-14 per cent recorded in the previous year, said rating agency ICRA in a report.

New Delhi, September 30: Mankind Pharma Limited's Fund Raising Committee has finalised a comprehensive plan to issue non-convertible debentures (NCDs) and commercial papers (CP) to raise a total of Rs 5,000 crore on Monday.

New Delhi, Sep 26: The upcoming 50 pharma manufacturing plants in the production-linked incentive (PLI) scheme will be completed in the next two years, the Centre informed on Thursday.

New Delhi, Sep 26: India is on the cusp of a transformative era in its pharmaceutical sector which is projected to reach $130 billion by 2030, a report showed on Thursday.

New Delhi, Sep 18: After achieving about 10 per cent growth last year, the Indian pharmaceuticals sector is again set to log a revenue growth of 8-10 per cent this fiscal, according to a report on Wednesday.

New Delhi, Sep 12: Driven by cardiac, antimalarial, and gastrointestinal therapies the Indian pharmaceutical market has seen more than 6 per cent growth in the month of August, according to a report.

New Delhi, Aug 28: From $14.9 billion in FY14 Indian pharma exports have surged to $27.9 billion -- more than 90 per cent growth in the last 10 years, said Jitin Prasada, Union Minister of State (MoS) for Commerce and Industry on Wednesday.

Hyderabad, Aug 27: Pharma giant Bharat Biotech on Tuesday announced the launch of an oral cholera vaccine (OCV) to help combat cholera which continues to pose a significant global public health challenge, especially in regions with inadequate sanitation.

New Delhi, Aug 27: Amid the current outbreak of Mpox, the Central Drugs Standard Control Organization (CDSCO) approved an indigenous RT-PCR test for the deadly infectious disease that delivers results in just 40 minutes, said Siemens Healthineers on Tuesday.

Mumbai, Aug 14: Glenmark Pharmaceuticals on Wednesday reported a more than two-fold jump in its net profit to Rs 462 crore for the April-June quarter of the current financial year compared to the corresponding figure of Rs 203 crore in the same quarter of the previous year.

Mumbai, Aug 1: The Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation approval to Sanofi for Beyfortus, used for the prevention of respiratory syncytial virus (RSV), in India, the drug major said on Thursday.

Hyderabad, July 30: Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company, on Tuesday announced that the World Health Organisation (WHO) has granted Pre-qualification (PQ) status to their Novel Oral Polio Vaccine type 2 (nOPV2).

Hyderabad, July 27: Dr Reddy's Laboratories on Saturday posted Rs 1,392 crore in net profit for the April-June quarter (year-on-year), down 1 per cent from Rs 1,402.5 crore in the same period in last fiscal.

Ahmedabad, July 19 : Indian pharma company Zydus Lifesciences on Friday said that it has received final approval from the US Food and Drug Administration (USFDA) to market tablets for Type 2 diabetes.

New Delhi, July 16: The Indian pharma and healthcare sector witnessed significant activity in the April-June quarter (Q2) this year with 55 deals totalling $4.1 billion, marking an 8 times increase in values and a 10 per cent rise in volumes over the previous quarter, a report showed on Tuesday.

Chennai, July 4: AstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of the pharma group AstraZeneca on Thursday said it will invest Rs 250 crore on expanding its Global Innovation and Technology Centre (GITC) here.

New Delhi, June 26: UK-based consumer healthcare company Haleon on Wednesday announced that it has entered into an agreement to sell its nicotine replacement therapy (NRT) business outside of the US to Dr Reddy's Laboratories SA for 500 million pounds (about $632.55 million).

Mumbai, June 21: Japan's Takeda Pharmaceutical gave India's Sun Pharmaceutical and Cipla the rights to commercialise the gastrointestinal drug Vonoprazan in the country.

New Delhi, June 14: Indian drug maker Zydus Lifesciences on Friday announced that it has received tentative approval from the United States Food and Drug Administration (USFDA) for hypertension drugs to market in the US.

New Delhi, May 29: The Indian Council of Medical Research (ICMR) along with the Pune-based National Institute of Virology (NIV) and other research institutes are set to launch phase-3 clinical trials of the recombinant dengue vaccine, said Apurva Chandra, Union Health Secretary on Wednesday.

New Delhi, May 25: Drug maker Aurobindo Pharma on Saturday announced that the US Food and Drug Administration (FDA) has classified Eugia Pharma Specialities' (a wholly owned subsidiary of the company) formulation manufacturing facility -- Unit III, as 'Official Action Indicated (OAI)'.

Mumbai May 22 : Sun Pharmaceutical Industries Ltd on Wednesday reported a 34 per cent jump in its consolidated net profit at Rs 2,654.5 crore for the January-March quarter of 2023-24, compared to the same period of the previous year.

Ahmedabad, May 22: Indian drug major Zydus Lifesciences on Wednesday received final approval from the US Food and Drug Administration (USFDA) to market Theophylline Extended-Release tablets to treat asthma.

Mumbai, May 22: Drugmaker Cipla on Wednesday announced that the US Food and Drug Administration (USFDA) has granted it final approval for the Lanreotide injection, used for the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumours (GEP-NETs).

New Delhi, May 21: French drugmaker Sanofi on Tuesday announced that it has partnered with artificial intelligence (AI) company OpenAI and tech-driven pharmaceutical firm Formation Bio to build AI-powered software to boost drug development and bring new medicines to patients more efficiently.

New Delhi, May 19: Drug makers Dr Reddy's Laboratories, Sun Pharma and Aurobindo Pharma are recalling their products in the US due to manufacturing issues.

New Delhi, May 11: Indian drug maker Zydus Lifesciences on Saturday announced receiving final approval from the US Food and Drug Administration (USFDA) to market a generic medication for arthritis and other conditions.

Ahmedabad, May 9: Indian drug maker Zydus Lifesciences on Thursday announced receiving final approval from the US Food and Drug Administration (USFDA) to market Dapsone Gel, 7.5 per cent.

Mumbai, May 7: Dr Reddy's Laboratories on Tuesday reported a 36 per cent jump in net profit at Rs 1,307 crore for the Jan-March quarter of 2023-24 compared to the corresponding figure of Rs 960 crore in the same period of the previous year.

New Delhi, May 5: Drug makers Cipla and Glenmark are recalling their products from the US market due to manufacturing issues.

Hyderabad, May 2 : Bharat Biotech on Thursday said that its Covid-19 vaccine Covaxin has an excellent safety record without any vaccine-associated incidents of blood clots, thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc, as it was developed with a single-minded focus on safety first, followed by efficacy.

New Delhi, May 2: Akums Drugs and Pharmaceuticals on Thursday launched Amlodipine, Telmisartan & Metoprolol (ER) film-coated tablets, a fixed-dose combination (FDC) medication approved by the Drugs Controller General of India (DCGI) for the management of resistant hypertension with stable coronary artery disease.

Hyderabad, March 24: Bharat Biotech International Ltd has started clinical trials of the Tuberculosis vaccine MTBVAC on adults in India, the company said on Sunday.

Chennai, March 19: Pharma major Dr Reddy's Laboratories Ltd on Tuesday announced the launch of its cancer drug Versavo (bevacizumab) in the UK.

Mumbai, March 12: Emcure Pharmaceuticals has announced its foray into the over-the-counter (OTC) market with the launch of its flagship product, Galact.

Chennai, Feb 23: Vertically integrated pharma player Orchid Pharma Ltd said on Friday that it will launch its Enmetazobactam drug in the US in the next couple of quarters.

Mumbai, Jan 31: Sun Pharmaceutical Industries Ltd on Wednesday reported a 16.52 per cent rise in net profit at Rs 2,523.75 crore for the October-December quarter of the current financial year on the back of strong sales in the domestic and US markets.

New Delhi, Jan 18: Sun Pharma has entered into a definitive merger agreement with Taro Pharmaceutical Industries pursuant to which Sun Pharma has agreed to acquire all of the outstanding ordinary shares of Taro not currently held by Sun Pharma.

New Delhi, Jan 6: Health Ministry on Saturday issued a new set of stringent guidelines to ensure that pharmaceutical companies follow good manufacturing practices and comply with quality standards for their products.